2017

Tecan with significant increase in sales and profit

Tecan Group AG / 2017: Tecan with significant increase in sales and profit . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Financial results: full-year and second half of 2017

• Order entry of CHF 564.1 million (2016: CHF 503.2 million)
  • Full-year growth of 11.8% in local currencies or 12.1% in Swiss francs
  • Double-digit growth rates in both business segments
• Sales of CHF 548.4 million (2016: CHF 506.2 million)
  • Full-year growth of 8.0% in local currencies and 8.3% in Swiss francs
  • H2 growth of 8.0% in local currencies and 8.9% in Swiss francs
• Full-year operating profit before depreciation and amortization (EBITDA) of CHF 105.3 million (2016: CHF 89.0 million)
  • Reported EBITDA margin of 19.2% (2016: 17.6%), after acquisition-related integration costs
  • Strong improvement in the EBITDA margin of 160 basis points, driven by substantial efficiency improvements together with some one-time effects
• Full-year net profit of CHF 66.5 million (2016: CHF 54.5 million); increase of 22.0% 
  • Net profit margin including integration costs of 12.1% (2016: 10.8%)
  • Increase in earnings per share by 20.9% to CHF 5.73 (2016: CHF 4.74)
• Cash flow from operating activities of CHF 99.4 million (2016: CHF 118.8 million; including a repayment of development costs)

Operating highlights 2017 and other important information

• Integration of US company SPEware (now Tecan SP) and market launch of the Resolvex(TM) product line for sample preparation for mass spectrometry
• Acquisition of Pulssar Technologies S.A.S. in February 2017 to expand the technology portfolio in Partnering Business; relocation of production completed
• Signing of new platform development projects with DiaSorin and Sysmex in Partnering Business
• Increase in the dividend proposed from CHF 1.75 to CHF 2.00 per share

Outlook 2018